Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

TGBA01AD

From Wikipedia, the free encyclopedia
Investigational antidepressant drug

Pharmaceutical compound
TGBA01AD
Clinical data
Other namesFKB01MD
Routes of
administration
By mouth
Pharmacokinetic data
Bioavailability17%[1]
Eliminationhalf-life4 hours[1]

TGBA01AD (also known asFKB01MD) is aserotonin reuptake inhibitor,5-HT1A and5-HT1D receptoragonist, and5-HT2 receptorantagonist which is under development byFabre-Kramer for the treatment ofmajor depressive disorder.[2][1][3] It has been inphase IIclinical trials since 2009, and as of January 2016, remains in this phase of development.[4]

See also

[edit]

References

[edit]
  1. ^abc"FKB01MD".Fabre-Kramer.
  2. ^"Drugs in Clinical Development for Major Depressive Disorder".Pharmaceutical Medicine.27 (1):35–42. 2013.doi:10.1007/s40290-013-0007-5.ISSN 1178-2595.S2CID 16286323.
  3. ^Żmudzka E, Sałaciak K, Sapa J, Pytka K (October 2018). "Serotonin receptors in depression and anxiety: Insights from animal studies".Life Sciences.210:106–124.doi:10.1016/j.lfs.2018.08.050.PMID 30144453.S2CID 52090587.
  4. ^"TGBA01AD".AdisInsight. Springer Nature Switzerland AG.
DATTooltip Dopamine transporter
(DRIsTooltip Dopamine reuptake inhibitors)
NETTooltip Norepinephrine transporter
(NRIsTooltip Norepinephrine reuptake inhibitors)
SERTTooltip Serotonin transporter
(SRIsTooltip Serotonin reuptake inhibitors)
VMATsTooltip Vesicular monoamine transporters
Others
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Stub icon

Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=TGBA01AD&oldid=1254858289"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp